润都股份(002923.SZ)：通过欧洲药品质量管理局现场检查

Core Viewpoint - Company successfully passed the on-site GMP inspection by the European Directorate for the Quality of Medicines (EDQM) for its active pharmaceutical ingredients (API) CEP, indicating compliance with EU GMP standards and enhancing its competitiveness in the European market [1] Group 1 - The inspection took place from May 14 to May 16, 2025, and the company received the inspection certificate from EDQM [1] - The successful inspection lays a solid foundation for the company to further expand its API market in Europe [1] - This achievement is expected to boost the company's international market expansion efforts and positively impact its future development [1]